Immunovant, Inc. (IMVT)

NASDAQ

$29.93

$-0.34

(-1.12%)

Regular Market

Immunovant, Inc. (IMVT) Live Price Chart

Last updated: ⁦2026-10-12 14:25:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Immunovant, Inc. (IMVT) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $29.93, with a market capitalization of $6.29B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $16.77 to $45.42. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$6.29B
Open	$30.17
Day's High	$53.75
Day's Low	$3.15
Previous Close	$30.47
Volume	80.36K
Average Volume	1.25M
P/E Ratio	--
52-Week High	$45.42
52-Week Low	$16.77
Dividend Yield	--
Earnings Date	--

Immunovant, Inc. (IMVT) Stock Price Today

Immunovant, Inc. (IMVT) is currently trading at $29.93 as of 2026-10-12 14:23:00, down 1.79% ($0.54) from the previous close of $30.47

During today's regular trading session, IMVT has traded between $3.15 and $53.75, with a trading volume of 80.36K shares. The current price is near the middle of today's range.

Immunovant, Inc. (IMVT) 7-Day Stock Price Change

Over the past seven days, Immunovant, Inc. (IMVT) moved from $33.65 to $29.93, representing a decline of 11.07% ($3.72).

The stock traded between $29.80 and $34.60 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 1.41 million shares, down versus the previous seven-day period, indicating lower trading activity.

IMVT 52-Week Price Position

Position in Range: 45.9%

52W Low$16.77

52W High$45.42

IMVT is currently trading at $29.93, placing it 45.9% of the way from its 52-week low of $16.77 to its 52-week high of $45.42. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Immunovant, Inc. (IMVT)?

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The Company operates in a single operating segment and has one reportable segment, which includes all activities related to the discovery, development and manufacturing of its product candidates.

Immunovant, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	315
Exchange	NASDAQ
Company Website	https://www.immunovant.com

How to Buy Immunovant, Inc. (IMVT) Stock on MEXC

Eligible investors can buy real shares of Immunovant, Inc. (IMVT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for IMVT and Place Your Order

Open the RealStocks trading page and search for IMVT. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Immunovant, Inc. (IMVT) stock price today?

Immunovant, Inc. (IMVT) is currently trading at $ 29.93, down 1.79% ($0.54) from the previous close of $ 30.47. Intraday prices update in real time during regular trading hours.

2.Is IMVT stock going up or down today?

As of 2026-10-12 14:23:00, IMVT is trading at $ 29.93, down 1.79% ($0.54) from its previous close of $ 30.47. The stock has traded between $ 3.15 and $ 53.75 during today’s regular session. Past price movements do not guarantee future results.

3.What is IMVT pre-market price?

As of 2026-10-12 14:23:00, IMVT is trading at $ 30.49 in pre-market trading, up 0.07% ($0.02) from the previous close of $ 30.47. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is IMVT after-hours price?

As of 2026-10-12 14:23:00, IMVT is trading at $ 30.48 in after-hours trading, up 0.02% ($0.01) from the regular-session close of $ 30.47. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is IMVT stock trading now?

IMVT trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does IMVT sit relative to its 52-week high and low?

Over the past 52 weeks, IMVT has traded between a low of $ 16.77 and a high of $ 45.42. At $ 29.93, the stock is positioned 45.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Immunovant, Inc. in?

Immunovant, Inc. (IMVT) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Immunovant, Inc.'s market capitalization and where is it listed?

Immunovant, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 6.29B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is IMVT valued in terms of P/E ratio and EPS?

IMVT trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.61. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Immunovant, Inc. pay a dividend?

Immunovant, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.